Home
OE Originals
OE Insights
CME
All Specialties
Arthroplasty
Cannabis
Ev. Based Medicine
Foot & Ankle
General Orthopaedics
Hand & Wrist
Metabolic Disorders
Osteoarthritis
Pediatric Orthopaedics
Peri-Operative
Phys. Therapy & Rehab
Shoulder & Elbow
Spine
Sports Medicine
Trauma
Tumour

Author Interviews

Conference Reports

PeerView

All Videos
(146 Videos)

Education
(9 Videos)
Innovation
(0 Videos)
Leadership
(3 Videos)
OrthoJoe
(21 Videos)
Other
(14 Videos)
Personal Growth
(1 Videos)
Practice
(2 Videos)
Research
(20 Videos)

COVID-19 Resource Center

OE World Tour

OE Perspectives

OE Ideas

OE Recommends

To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Loading...
Search Filters

Date Range

to

Report Types

ALL
RCT
META
ACE Reviews

Condition

Specialties

See all (18)

Emerging Treatments

OE Recommends Topics

Multimedia

Journal

Conference Series

Evidence Series

We found 5 results matching your search query: "Solvay"

Showing 1 - 5 of 5
Read Ace Report

Dronabinol improves chronic non-cancer pain when added to standard opioid therapy

J Pain. 2008 Mar;9(3):254-64

RCT Cannabis Pain Solvay Opioid - Hide
Read Ace Report

Cannabis extract and THC improve pain in patients with multiple sclerosis

Lancet. 2003 ;362(9385):1517-26.

RCT Cannabis Pain Solvay Solvay Pharmaceuticals Extract Placebo - Hide
Read Ace Report

Dronabinol effective in reducing central lesion pain from multiple sclerosis after 3-week treatment

BMJ. 2004 Jul 31;329(7460):253

RCT Cannabis Lesion Inflammation Pain Solvay Solvay Pharmaceuticals Placebo - Hide
Read Ace Report

Oral dronabinol and smoked cannabis have similar psychoactive effects, but peak at different times

Clin J Pain. 2014 Jun;30(6):472-8. doi: 10.1097/AJP.0000000000000022

RCT Cannabis Pain Solvay Solvay Pharmaceuticals - Hide
Read Ace Report

Fenofibrate produces a reduction in amputation events in type II diabetics

Lancet. 2009 May 23;373(9677):1780-8

RCT General Orthopaedics Diabetes Laboratoires Fournier Solvay Solvay Pharmaceuticals Fenofibrate Placebo Reduction - Hide
Showing 1 - 5 of 5